AR099829A1 - Formulaciones veterinarias antihelmínticas estables - Google Patents

Formulaciones veterinarias antihelmínticas estables

Info

Publication number
AR099829A1
AR099829A1 ARP150100871A ARP150100871A AR099829A1 AR 099829 A1 AR099829 A1 AR 099829A1 AR P150100871 A ARP150100871 A AR P150100871A AR P150100871 A ARP150100871 A AR P150100871A AR 099829 A1 AR099829 A1 AR 099829A1
Authority
AR
Argentina
Prior art keywords
stable
antihelmintic
veterinary formulations
formulations
anthelmintic
Prior art date
Application number
ARP150100871A
Other languages
English (en)
Inventor
Yeritsyan Karen
Original Assignee
Donaghys Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Donaghys Ltd filed Critical Donaghys Ltd
Publication of AR099829A1 publication Critical patent/AR099829A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Organic Chemistry (AREA)
  • Environmental Sciences (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Toxicology (AREA)

Abstract

Formulaciones veterinarias antihelmínticas estables. Se describen formulaciones estables que comprenden al menos una lactona macrocíclica y levamisol como agentes antihelmínticos activos, opcionalmente también con al menos un antihelmíntico de la clase de los bencimidazoles.
ARP150100871A 2014-03-24 2015-03-25 Formulaciones veterinarias antihelmínticas estables AR099829A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NZ622869A NZ622869A (en) 2014-03-24 2014-03-24 Stable veterinary anthelmintic formulations

Publications (1)

Publication Number Publication Date
AR099829A1 true AR099829A1 (es) 2016-08-24

Family

ID=52464905

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP150100871A AR099829A1 (es) 2014-03-24 2015-03-25 Formulaciones veterinarias antihelmínticas estables

Country Status (11)

Country Link
US (1) US10449179B2 (es)
EP (1) EP3122352A4 (es)
CN (1) CN106132409B (es)
AR (1) AR099829A1 (es)
AU (3) AU2015237371A1 (es)
CA (1) CA2942008C (es)
MX (1) MX2016012319A (es)
NZ (2) NZ622869A (es)
RU (1) RU2711200C2 (es)
UY (1) UY36045A (es)
WO (1) WO2015147655A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018038623A1 (en) * 2016-08-23 2018-03-01 Donaghys Limited Improvements in parasite treatments
WO2018167271A1 (en) 2017-03-17 2018-09-20 Krka, D.D., Novo Mesto Stable topical veterinary composition
WO2020027881A1 (en) 2018-08-03 2020-02-06 Nectero Medical, Inc. Purified pentagalloyl glucose and devices for delivery
JP7199653B2 (ja) * 2018-08-17 2023-01-06 住化エンバイロメンタルサイエンス株式会社 樹脂製容器入り外部寄生虫駆除剤
WO2020198371A1 (en) * 2019-03-26 2020-10-01 Nectero Medical, Inc. Methods and devices for treatment of post-surgery laxity of tendons and tendon repair
CN111840234A (zh) * 2020-08-14 2020-10-30 瑞普（天津）生物药业有限公司 一种兽用复方驱虫颗粒剂及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8327761D0 (en) * 1983-10-17 1983-11-16 Janssen Pharmaceutica Nv Parasiticidal formulations
NZ248486A (en) 1993-08-24 1996-07-26 Ashmont Holdings Limited Subst Stable anthelmintic formulation containing closantel and one or more avermectins or milbemycins in a glycol based solvent
DE19654079A1 (de) * 1996-12-23 1998-06-25 Bayer Ag Endo-ekto-parasitizide Mittel
CA2211949A1 (en) * 1997-07-21 1999-01-29 David Farley Johnson Nonaqueous compositions for parenteral administration
NZ336139A (en) 1999-06-04 2002-07-26 Nufarm Ltd Pesticidal emulsion composition containing levamisole in the aqueous phase and an anthelmintic in the organic phase
NZ515772A (en) 1999-06-04 2002-12-20 Nufarm Ltd Pesticidal emulsion composition containing levamisole in the aqueous phase and an anthelmintic in the organic phase
MXPA05010659A (es) 2003-04-04 2005-12-12 Merial Ltd Formulaciones veterinarias antihelminticas topicas.
NZ535644A (en) 2003-07-25 2007-05-31 Ashmont Holdings Ltd Anthelmintic formulations
JP2009508853A (ja) 2005-09-15 2009-03-05 メリアル リミテッド 駆虫製剤
NZ552040A (en) * 2006-12-13 2009-04-30 Bomac Research Ltd Veterinary formulation comprising an anthelmintic compound and glyceryl acetate
RU2367435C1 (ru) * 2008-03-26 2009-09-20 Александр Анатольевич Смирнов Состав для лечения гельминтозов домашних животных
AR081970A1 (es) 2010-06-24 2012-10-31 Intervet Int Bv Formulacion inyectable de una lactona macrociclica y levamisol, formulacion y uso veterinario
NZ594610A (en) * 2011-08-16 2013-03-28 Virbac New Zealand Ltd Injectable Anthelmintic Formulations cotaining levamisole and one or more macrocyclic lactones for controlling internal parasites in ruminants
WO2013043064A1 (en) * 2011-09-23 2013-03-28 Alleva Animal Health Limited Veterinary anthelmintic delivery system

Also Published As

Publication number Publication date
CA2942008A1 (en) 2015-10-01
CA2942008C (en) 2022-06-21
RU2016140272A3 (es) 2018-09-26
UY36045A (es) 2015-07-31
US20170007584A1 (en) 2017-01-12
NZ622869A (en) 2015-01-30
EP3122352A4 (en) 2017-11-01
AU2022252717B2 (en) 2024-09-05
CN106132409A (zh) 2016-11-16
AU2020227063A1 (en) 2020-09-24
CN106132409B (zh) 2020-09-01
EP3122352A1 (en) 2017-02-01
AU2022252717A1 (en) 2022-11-03
US10449179B2 (en) 2019-10-22
WO2015147655A1 (en) 2015-10-01
AU2015237371A1 (en) 2016-09-15
RU2711200C2 (ru) 2020-01-15
MX2016012319A (es) 2017-01-06
RU2016140272A (ru) 2018-04-24
NZ701697A (en) 2016-05-27

Similar Documents

Publication Publication Date Title
ECSP17016797A (es) Indazoles sustituidos con benzilo como inhibidores de bub1
AR099829A1 (es) Formulaciones veterinarias antihelmínticas estables
CL2017001987A1 (es) Derivados de 1-(het)arilsulfonil-(pirrolidin o piperidin)-2-carboxamida y su uso como antagonistas de trpa1
UY34605A (es) Derivados de arilalquiloxipirimidina e insecticidas agrohortícolas que comprenden dichos derivados como principios activos, y método de uso de los mismos
UY34617A (es) Composiciones veterinarias orales parasiticidas que comprenden agentes activos de acción sistémica, métodos y usos de las mismas
UY34578A (es) Nuevos derivados de indolizina, su procedimiento de preparación y las composiciones farmacéuticas q ue los contienen
CL2015003280A1 (es) Derivados de benzimidazol como inhibidores de bromodominio
CL2016000106A1 (es) Sulfonamidas como moduladores de canales de sodio.
CL2019001339A1 (es) Inhibidores de la magl.
BR112017005381A2 (pt) composições que compreendem células recombinantes de bacillus e um inseticida.
CO2019005038A2 (es) Inhibidores de magl
UY34632A (es) Compuestos de oxazolidin- 2- ona y usos de los mismos
NZ631152A (en) Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride
CR20170111A (es) Derivados de benzodiazepina citotóxicos
BR112017005504A2 (pt) composições que compreendem células recombinantes de bacillus e um inseticida.
CL2017001025A1 (es) Compuestos para usarse en el tratamiento antihelmíntico
CO2018004573A2 (es) Derivados de fenilo como agonistas del receptor 2 de cannabinoides
UY34610A (es) Pirroldicarboxamidas condensadas y su uso como agentes farmacéuticos.
CO2017012645A2 (es) Agente antihipertensivo que comprende s-1-propenilcisteína o una sal del mismo como ingrediente activo
GT201700280A (es) Formulación sólida oral que contiene irinotecán y método de preparación de la misma
DK3232780T3 (da) Vandige adjuvans-sammensætninger, der indeholder elektrolyt, sammensætninger, som indeholder et aktivt stof, og anvendelse deraf
MX2020004133A (es) Oligosacaridos inmunomoduladores.
UY34761A (es) Composiciones parasiticidas que comprenden derivados de benzimidazol, métodos y usos de los mismos.
DK3649688T3 (da) Dobbeltaktive katodematerialer
CL2016001130A1 (es) Composiciones sólidas de triglicéridos y usos de estas

Legal Events

Date Code Title Description
FG Grant, registration